erythrosine has been researched along with imatinib mesylate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamada, A; Miyano, H; Saito, H; Watanabe, H | 1 |
Barnes, DJ; Melo, JV | 1 |
1 review(s) available for erythrosine and imatinib mesylate
Article | Year |
---|---|
Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia.
Topics: Benzamides; Cell Proliferation; Drug Resistance, Neoplasm; Fluoresceins; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Stem Cells; Succinimides | 2006 |
1 other study(ies) available for erythrosine and imatinib mesylate
Article | Year |
---|---|
Interaction of imatinib mesilate with human P-glycoprotein.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Biological Transport; Cell Line; Drug Interactions; Fluoresceins; Fluorescent Dyes; Humans; Imatinib Mesylate; Piperazines; Pyrimidines; Rhodamine 123; Tumor Cells, Cultured | 2003 |